Darbesis Injection 60 mcg/0.3 ml contains Darbepoetin Alfa, a long-acting erythropoiesis-stimulating agent (ESA) used for the treatment of anemia, particularly in patients with chronic kidney disease (CKD) and those undergoing chemotherapy. It works by stimulating red blood cell production in the bone marrow, thereby increasing hemoglobin levels and reducing the need for blood transfusions.

This formulation offers extended dosing intervals compared to conventional erythropoietin, making it convenient for patients requiring long-term therapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each prefilled syringe contains:

• Darbepoetin Alfa 60 mcg in 0.3 ml

Mechanism of Action

Darbepoetin Alfa is a recombinant form of human erythropoietin with a longer half-life. It binds to erythropoietin receptors on erythroid progenitor cells in the bone marrow, stimulating their proliferation and differentiation into mature red blood cells. This leads to increased red blood cell count and improved oxygen-carrying capacity of the blood.

Indications

Darbesis Injection 60 mcg/0.3 ml is indicated for:

• Anemia associated with chronic kidney disease (CKD) in adults and pediatric patients
• Anemia in patients receiving chemotherapy for non-myeloid malignancies
• Reduction in the need for red blood cell transfusions
• Management of anemia due to reduced endogenous erythropoietin production

Dosage and Administration

• Administered by subcutaneous (SC) or intravenous (IV) injection under medical supervision
• Dosage is individualized based on body weight, hemoglobin level, and patient response
• Typically administered once weekly or once every two weeks
• Hemoglobin levels should be monitored regularly
• Dose adjustments are required to maintain target hemoglobin levels

Contraindications

Darbesis Injection should not be used in:

• Known hypersensitivity to Darbepoetin Alfa or erythropoietin products
• Uncontrolled hypertension
• Pure red cell aplasia following ESA therapy
• Patients with severe allergic reactions to formulation components

Side Effects

Possible side effects include:

• Hypertension
• Headache
• Injection site reactions
• Edema (fluid retention)
• Thromboembolic events (e.g., deep vein thrombosis)
• Fever or flu-like symptoms
• Rare allergic reactions

Precautions

• Blood pressure should be controlled before starting therapy
• Regular monitoring of hemoglobin levels is essential
• Avoid excessive rise in hemoglobin to reduce cardiovascular risk
• Ensure adequate iron stores for optimal response
• Use cautiously in patients with cardiovascular disease or history of stroke

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Darbesis Injection may interact with:

• Iron supplements (often co-administered)
• Antihypertensive medications
• Other agents affecting red blood cell production

Storage Conditions

• Store at 2°C to 8°C in a refrigerator
• Do not freeze or shake
• Protect from light
• Keep out of reach of children.